​

Funding Round

Seed Round - Karma Biotechnologies

Seed Round - Karma Biotechnologies

Investment Firm

Overview

Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.

Announced Date

Sep 03, 2019

Funding Type

Seed

Highlights

Location

United States, North America

Social

Investor Lead

Khosla Ventures

Khosla Ventures

Khosla Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorPresight Capital
Participant InvestorSOSV
Participant InvestorWilliam Woodward
Participant InvestorKhosla Ventures

Round Details and Background

Karma Biotechnologies raised $2100000 on 2019-09-03 in Seed Round

Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 03, 2019
Seed Round - Karma Biotechnologies
5-2.1M
Sep 01, 2021
Seed Round - Karma Biotechnologies
9-2.8M
May 31, 2023
Seed Round - Karma Biotechnologies
1-undefined

Recent Activity

There is no recent news or activity for this profile.